Source link : https://www.newshealth.biz/health-news/fda-approves-first-drug-for-classic-congenital-adrenal-hyperplasia-in-70-years/
The FDA approved crinecerfont (Crenessity) as a first-in-class treatment for classic congenital adrenal hyperplasia (CAH), the agency announced late Friday. Crinecerfont was approved for use in combination with glucocorticoids in patients ages 4 years and older with the rare genetic condition that impacts the adrenal glands. Acting as a potent and selective oral corticotropin-releasing factor […]
Author : News Health
Publish date : 2024-12-16 17:57:06
Copyright for syndicated content belongs to the linked Source.